The FDA granted fast track designation for rezpegaldesleukin for treating adults and children aged 12 years and older, ...

AbbVie on Wednesday said the Phase 3 study evaluating the safety and efficacy of Rinvoq in adults and adolescents with severe alopecia areata met its primary endpoint of 80% or more scalp hair ...

Patients' perceptions and stigma of alopecia areata have a stronger effect on their mental health and quality of life than ...

AbbVie (NYSE: ABBV) today announced positive topline results from the first of two pivotal studies of the Phase 3 UP-AA clinical program evaluating the safety and efficacy of upadacitinib (RINVOQ®; 15 ...

Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleukin for the treatment of severe-to-very severe ...

A new service at a hair salon in Lackawanna County is aimed at helping those suffering from hair loss. 28/22 News has more ...

Alopecia areata (AA) has a severe psychosocial impact, which is linked to illness perceptions and stigma more strongly than disease severity.

Hair loss from rheumatoid arthritis is uncommon, but it can happen. The autoimmune disease itself doesn’t cause hair loss, but the medications used to treat rheumatoid arthritis can.

Losing hair is natural—most people shed about 50 to 150 hairs daily. But when the loss becomes noticeable, showing bald ...

Patients with primary cicatricial alopecia (PCA) have a greater risk of endocrine and metabolic disease development compared with patients with non–cicatricial alopecia (NCA) and those with no ...

Celiac disease is associated with an increased risk for developing alopecia areata, according to a letter to the editor published online Nov. 21 in the Journal of the American Academy of Dermatology.